IXICO PLC - ESG Rating & Company Profile powered by AI
The webpage includes a questions and answers section for IXICO PLC. Other corporations in the scoring peer group for IXICO PLC are shownin the table. If you work at IXICO PLC and you wish to licence your ESG aseessment, please contact us.
IXICO PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | IXICO PLC | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does IXICO PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes IXICO PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes IXICO PLC report the average age of the workforce?
Sign up for free to unlockDoes IXICO PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes IXICO PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes IXICO PLC disclose cybersecurity risks?
Sign up for free to unlockDoes IXICO PLC offer flexible work?
Sign up for free to unlockDoes IXICO PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes IXICO PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes IXICO PLC conduct supply chain audits?
Sign up for free to unlockDoes IXICO PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes IXICO PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes IXICO PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes IXICO PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes IXICO PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes IXICO PLC disclose water use targets?
Sign up for free to unlockDoes IXICO PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid IXICO PLC have a product recall in the last two years?
Sign up for free to unlockDoes IXICO PLC disclose incidents of discrimination?
Sign up for free to unlockDoes IXICO PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas IXICO PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes IXICO PLC disclose parental leave metrics?
Sign up for free to unlockDoes IXICO PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes IXICO PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes IXICO PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes IXICO PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes IXICO PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes IXICO PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs IXICO PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes IXICO PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes IXICO PLC disclose its waste policy?
Sign up for free to unlockDoes IXICO PLC report according to TCFD requirements?
Sign up for free to unlockDoes IXICO PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes IXICO PLC disclose energy use targets?
Sign up for free to unlockDoes IXICO PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes IXICO PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for IXICO PLC
These potential risks are based on the size, segment and geographies of the company.
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.